TMG and NMN: Do You Need Both, and What Ratio?

Affiliate disclosure: Biohack Blueprint may earn a commission from qualifying DoNotAge purchases through our links.

TMG and NMN are often sold as a pair because they connect to methyl-group and NAD+ metabolism. The connection is biologically plausible. It does not establish that everyone taking NMN becomes methyl-donor deficient or that matching the two supplements gram for gram improves health.

To make a useful decision, separate the mechanism, the human evidence and the practical capsule calculations. They answer different questions.

NMN and TMG do different jobs

NMN, or nicotinamide mononucleotide, is an NAD+ precursor. TMG is trimethylglycine, also called betaine anhydrous. TMG can donate a methyl group through the betaine-homocysteine methyltransferase pathway, helping recycle homocysteine to methionine. It is not itself an NAD+ precursor. [1]

Nicotinamide metabolism includes methylation reactions. That has led to concern that increased NAD+ precursor use could increase methyl-group demand. However, a pathway consuming methyl groups is not by itself proof of a clinically important deficiency at every supplement dose.

Question	Evidence needed	What is established?
Can betaine participate in methyl-group metabolism?	Biochemical and human metabolism research	Yes
Does every NMN user need added TMG?	Direct human comparisons with relevant biomarkers and outcomes	A universal requirement is not established
Does a 1:1 ratio improve outcomes?	Trials comparing specified ratios or a justified dose strategy	A universal ratio is not established
Can a registered study settle the question?	Completed, reported results with assessable methods	A protocol alone cannot demonstrate benefit

Why a 1:1 milligram ratio is not a biochemical requirement

Five hundred milligrams of NMN and 500 mg of TMG are equal masses of different molecules. Equal mass does not mean equal molecule numbers, equal absorption or an equal metabolic requirement. NAD+ turnover also involves recycling and multiple pathways rather than a simple one-dose-in, one-methyl-donor-out equation.

The most relevant question is therefore not whether the capsule weights match. It is whether adding a defined amount of TMG to a defined NMN regimen changes a meaningful outcome compared with the same NMN regimen alone. A useful study would report the intervention, participants, duration, relevant metabolites, homocysteine, adverse effects and the outcome it was designed to test.

Statement	What would support it	Current interpretation
TMG participates in methyl donation	Biochemical and human metabolic evidence	Established chemistry
NMN always causes harmful methyl-donor depletion	Consistent direct human findings across the relevant doses and populations	Not established as a universal effect
TMG prevents a clinically important NMN-related problem	A suitable direct comparison with defined outcomes	A research question, not a benefit established by separate ingredient trials
The best ratio is 1:1	Comparative dose-ratio studies or another validated dosing strategy	A popular convention rather than a validated universal prescription

What does the human methylation evidence show?

TMG has its own human evidence. Trials show that betaine can lower homocysteine in defined populations and protocols. That is a reason to investigate the compound, but those trials did not show that a particular NMN amount creates a matching TMG requirement. [2]

A relevant contextual study is NR-SAFE, which tested nicotinamide riboside at 3 grams daily for four weeks in 20 people with Parkinson’s disease. It did not add TMG. The study reported an initial homocysteine rise without evidence of depletion of the measured methyl-donor pool. [3]

That result should not be stretched in either direction. It does not establish that high-dose NR is interchangeable with ordinary NMN use, and it does not demonstrate that everyone needs a methyl donor. It illustrates why the whole measured metabolic picture matters more than one theoretical reaction.

Direct combination research: results versus registration

A study asking whether adding TMG changes an NMN outcome is more directly relevant than separate ingredient studies. When reading an emerging trial, check the exact formulation, comparator, outcome and publication status. A multi-ingredient product cannot isolate the contribution of TMG, and registration alone is not evidence that a combination works.

As checked on 18 October 2026, NCT07144527 lists a recruiting study comparing NMN-plus-TMG and NMN interventions with placebo crossover periods. The official record has no posted results. It is relevant research in progress, rather than evidence that the combination works or validates a universal ratio.

Our TMG Data Center separates published papers from source registrations. It also distinguishes NR research from NMN research. For NMN’s broader trial literature, see the NMN human-trials guide.

Where did the 1:1 ratio come from?

A gram-for-gram ratio is easy to remember and appears in supplement advice. Ease of use is not clinical validation. There is no established universal rule that 500 mg NMN requires 500 mg TMG, or that doubling NMN automatically means doubling TMG.

The ratio also ignores differences in diet, baseline homocysteine, nutrient status, kidney function and the purpose of supplementation. A high homocysteine result can have several explanations; a genetic report or an influencer’s routine does not settle them.

For the underlying metabolism, read TMG, methylation and MTHFR. For NMN amounts themselves, use the separate NMN dosage guide.

How to read an NMN and TMG routine

Example label	Amount in one unit	What to check
TMG capsule	500 mg TMG	How many capsules make the labeled daily serving?
NMN capsule or powder	Product-specific	Read its own label; do not assume the same strength as TMG
Combined longevity blend	Several active ingredients	Whether each amount is disclosed and what evidence tests the actual combination

DoNotAge Pure TMG contains 500 mg per capsule and lists a 1,000 mg daily serving. That means two capsules for the listed TMG amount. The arithmetic does not prove that 1,000 mg of NMN should accompany it.

If you are comparing this option, our 5/5 Pure TMG review covers its formula and value. Our review score is for the product offering; it is not evidence of a universal NMN pairing requirement.

A worked label example without assuming a required stack

Suppose an NMN label supplies 500 mg in its stated serving and a TMG label supplies 500 mg per capsule. One TMG capsule would make the two amounts equal in milligrams. Two TMG capsules would supply 1 g. Neither calculation demonstrates which regimen is needed, more effective or safer for that person.

For DoNotAge Pure TMG, the product page’s listed daily serving is two 500 mg capsules. If another product already contains betaine, count that as well. Do not change the serving just because an online ratio seems to demand a matching amount. The dosage guide separates product directions from the amounts used in research.

What NR-SAFE can and cannot answer

NR-SAFE is useful because it actually measured parts of the methylation question during high-dose nicotinamide riboside exposure. But its 20 participants had Parkinson’s disease, the tested precursor was NR rather than NMN, the amount was 3 g/day and follow-up was four weeks. It was not a trial of ordinary NMN users randomly assigned to added TMG versus no TMG. ^[3]

Its finding of an initial homocysteine rise without measured methyl-pool depletion challenges a simplistic “one reaction empties the tank” story. It does not establish the long-term safety of every NAD+ regimen or show that betaine cannot help any subgroup. The exact population and comparison should stay attached to the result.

What to look for when direct-combination results appear

A registered crossover study can be informative, but interpretation depends on the actual groups, washout, carryover assessment, adherence and published results. NCT07144527 remains research in progress in the official record checked for this guide. Its protocol should not be cited as proof that the pairing works, and a change to a registry description is not a new efficacy result.

In the meantime, use a clear reason for each ingredient. Fatigue, a common MTHFR variant or the wish to optimize an unmeasured “methylation level” does not by itself identify a TMG need. Persistent symptoms or an abnormal test deserve assessment on their own terms.

Should you take them together in the morning?

A shared routine can be convenient. Human outcome evidence does not establish that swallowing NMN and TMG at the same moment is necessary, or that a specific morning window creates superior methylation.

Follow each label and consider tolerance. Our TMG timing guide and NMN timing guide address the practical questions without treating the pair as a validated medicine.

What if you also take resveratrol?

Adding a third ingredient does not validate the original ratio. Separate studies of NMN, TMG or resveratrol cannot establish that the whole stack is synergistic, nor identify the best amount of each ingredient.

For product combinations, check the full formula and the tested population. For individual products, review each reason for use and any medicines involved. The NMN and resveratrol guide keeps that question separate from TMG’s homocysteine evidence.

What direct evidence would make the combination more convincing?

The decisive comparison would hold NMN constant and randomly add a defined TMG regimen, with an appropriate control and prespecified outcomes. It would measure whether TMG changes a relevant clinical or metabolic result, rather than merely showing that both compounds participate in adjacent pathways.

The NR-SAFE trial is informative about high-dose nicotinamide-riboside metabolism, but it did not test an NMN-plus-TMG stack. Its short Parkinson’s-disease population, NAD-related measurements and methyl-donor findings cannot validate a universal 1:1 NMN-to-TMG ratio. Keep the precursor and population explicit. ^[3]

For a reader choosing the products separately, clear active amounts are an advantage: DoNotAge’s 500 mg TMG unit is easy to count. The remaining question is whether adding it serves a defined purpose. A convenient product pairing should not be presented as proof that every NMN user is otherwise depleting methyl donors or preventing NAD+ formation.

When a blood test or clinical review is more useful than a ratio

If elevated homocysteine, a nutrient deficiency or a medical condition is driving your interest, start with that issue. B12, folate, renal function, dietary intake and the complete treatment history may be more informative than matching milligrams on two bottles.

TMG also has its own safety considerations, including dose-specific lipid findings and digestive symptoms. [4] Review the safety guide before increasing it to follow a stack. A practical routine should make the decision clearer, rather than create a new supplement requirement without evidence.

Sources and next steps

Browse the complete 415-publication TMG Data Center for the original studies, methods, disclosures and limitations. The numbered references below identify the sources used for this article; the full library also retains supporting and null evidence.

Continue by question: TMG Supplement: Benefits, Dosage, Safety and Research · TMG Dosage Guide: Study Doses and Capsule Calculations · TMG Side Effects: Cholesterol, Digestion and Safety · TMG for Homocysteine: Dose, Results and Limitations.

Our recommended TMG product

DoNotAge Pure TMG — 5/5 editorial rating

Our first choice for a straightforward single-active capsule: 500 mg TMG per capsule, a vegan capsule and 60 or 366 capsules. The score assesses the formula, label clarity and practical product choice; clinical evidence is judged separately.

Read the full evidence-led review · View at DoNotAge. Use BB10 for 10% off eligible standalone products; confirm current checkout terms.

Affiliate disclosure: Biohack Blueprint may earn a commission from qualifying purchases. This is a desk-based editorial recommendation, not an independent batch assay or a promise of a health outcome.